Skip to main content
    P

    Prestige Brand Holdings Inc (PBH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $49.23
    +0.83 (+1.71%)

    Market Cap: $2.29B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    82%(32/39)
    Avg Surprise
    +3.20%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.07
    Range$1.05 - $1.08
    7 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$1.10-2.9%
    60d ago$1.15-6.8%
    30d ago$1.070.0%
    7d ago$1.070.0%
    Current$1.07
    Revenue Consensus
    $329M
    Range$329M - $330M
    7 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.24
    Range$1.20 - $1.31
    7 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$1.25-0.7%
    60d ago$1.24+0.3%
    30d ago$1.240.0%
    7d ago$1.240.0%
    Current$1.24
    Revenue Consensus
    $353M
    Range$348M - $369M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$1.38---
    Dec 26EST
    		-$1.24---
    Sep 26EST
    		-$1.07---
    Jun 26
    Reported Aug 6
    		$0.98$0.89+10.11%Beat+3.2%
    Mar 26
    Reported May 13
    		$1.23$1.39-11.51%Miss-6.8%
    Dec 25
    Reported Feb 5
    		$1.14$1.16-1.72%Miss-6.6%
    Sep 25
    Reported Nov 6
    		$0.86$0.97-11.34%Miss-21.1%
    Jun 25
    Reported Aug 7
    		$0.95$1.01-5.94%Miss+5.6%
    Mar 25
    Reported May 8
    		$1.32$1.29+2.33%Beat+29.4%
    Dec 24
    Reported Feb 6
    		$1.22$1.16+5.17%Beat+15.1%
    Sep 24
    Reported Nov 7
    		$1.09$1.08+0.93%Beat+1.9%
    Jun 24
    Reported Aug 8
    		$0.90$0.86+4.65%Beat-15.1%
    Mar 24
    Reported May 14
    		$1.02$1.14-10.53%Miss-4.7%
    Dec 23
    Reported Feb 8
    		$1.06$1.04+1.92%Beat+1.9%
    Sep 23
    Reported Nov 2
    		$1.07$1.07+0.00%Beat+4.9%
    Jun 23
    Reported Aug 3
    		$1.06$1.01+4.95%Beat-2.8%
    Mar 23
    Reported May 4
    		$1.07$1.04+2.88%Beat+17.6%
    Dec 22
    Reported Feb 2
    		$1.04$1.01+2.97%Beat+5.1%
    Sep 22
    Reported Nov 3
    		$1.02$1.00+2.00%Beat+0.0%
    Jun 22
    Reported Aug 4
    		$1.09$1.04+4.81%Beat-4.4%
    Mar 22
    Reported May 5
    		$0.91$0.89+2.25%Beat+15.2%
    Dec 21
    Reported Feb 3
    		$0.99$0.88+12.50%Beat+22.2%
    Sep 21
    Reported Nov 4
    		$1.02$0.99+3.03%Beat+30.8%
    Jun 21
    Reported Aug 5
    		$1.14$0.87+31.03%Beat+32.6%
    Mar 21
    Reported May 6
    		$0.79$0.78+1.28%Beat-3.7%
    Dec 20
    Reported Feb 4
    		$0.81$0.77+5.19%Beat+0.0%
    Sep 20
    Reported Nov 5
    		$0.78$0.72+8.33%Beat+14.7%
    Jun 20
    Reported Aug 6
    		$0.86$0.70+22.86%Beat+32.3%
    Mar 20
    Reported May 7
    		$0.82$0.74+10.81%Beat+13.9%
    Dec 19
    Reported Feb 6
    		$0.81$0.75+8.00%Beat+11.0%
    Sep 19
    Reported Oct 31
    		$0.68$0.66+3.03%Beat+4.6%
    Jun 19
    Reported Aug 1
    		$0.65$0.64+1.56%Beat-4.4%
    Mar 19
    Reported May 9
    		$0.72$0.70+2.86%Beat+16.1%
    Dec 18
    Reported Feb 7
    		$0.73$0.72+1.39%Beat+4.3%
    Sep 18
    Reported Nov 1
    		$0.65$0.63+3.17%Beat+6.6%
    Jun 18
    Reported Aug 2
    		$0.68$0.67+1.49%Beat+3.0%
    Mar 18
    Reported May 10
    		$0.62$0.61+1.64%Beat+14.8%
    Dec 17
    Reported Feb 1
    		$0.70$0.70+0.00%Beat+14.8%
    Sep 17
    Reported Nov 2
    		$0.61$0.66-7.58%Miss-
    Jun 17
    Reported Aug 3
    		$0.66$0.64+3.13%Beat-
    Mar 17
    Reported May 11
    		$0.54$0.55-1.82%Miss-
    Dec 16
    Reported Feb 2
    		$0.61$0.56+8.93%Beat-

    Key Metrics

    Valuation
    P/E Ratio11.69EV/EBITDA13.55x
    Price/FCF9.93xFCF Yield10.07%
    Profitability
    Profit Margin15.60%Operating Margin20.80%
    ROE9.12%ROIC5.18%
    Financial Health
    Debt/Equity1.07xInterest Coverage7.08x
    Current Ratio3.23xQuick Ratio1.99x
    Trading Statistics
    Beta0.34Avg Volume625.20K
    52-Week High$71.0752-Week Low$42.62

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$47.61
    SMA 20$46.90
    SMA 50$49.30
    SMA 200$54.89
    EMA 10$47.97
    EMA 20$47.72
    EMA 50$48.52
    EMA 200$54.08

    MACD

    Line: -0.01Signal: -0.49Hist: 0.49

    ADX

    ADX: 20.5+DI: 28.8-DI: 18.2

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down28.0
    PSAR$46.22

    Bollinger Bands

    Upper Band$49.62
    Lower Band$44.19
    %B Position1158%(Upper)
    Band Width0.93

    RSI (14-Day)

    Neutral
    57.4

    Momentum Oscillators

    Stoch %K74.5
    Stoch %D79.8
    Williams %R-25.0
    ROC (10d)10.0%
    Momentum4.46
    CCI (20d)164.1
    MFI (14d)67.5

    Volatility Measures

    ATR (14d)$1.46(3.0%)
    StdDev (20d)1.36
    Hist Vol31.9%(Moderate)

    Volume Flow

    VWAP$49.61
    OBV-1.6M
    AD Line-5.3M
    CMF (20d)-0.044

    Volume Metrics

    Avg Vol (20d)635.7K
    Vol Ratio0.8x
    VWMA (20d)$46.60

    Pivot Points

    R3$50.38
    R2$49.77
    R1$49.08
    Pivot Point$48.47
    S1$47.78
    S2$47.17
    S3$46.48

    Advanced Oscillators

    TSI-0.57
    Ultimate Osc52.8
    KST-31.39

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$265.71M$281.62M$283.44M$274.11M$249.53M$296.52M$290.32M$283.79M$267.14M$276.99M$282.74M$286.32M
    Cost of Revenue$129.52M$135.32M$126.08M$122.53M$109.20M$126.51M$129.27M$126.40M$121.12M$125.17M$124.80M$126.30M
    Gross Profit$136.19M$146.30M$157.37M$151.58M$140.33M$170.01M$161.05M$157.38M$146.02M$151.82M$157.94M$160.02M
    Operating Expenses$83.67M$70.81M$74.88M$71.91M$68.58M$81.58M$69.09M$73.04M$73.98M$69.66M$71.11M$71.77M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$43.30M$30.28M$29.67M$28.04M$28.46M$27.05M$26.18M$26.07M$28.91M$26.46M$26.00M$26.00M
    Operating Income$52.52M$75.49M$82.49M$79.67M$71.76M$88.43M$91.96M$84.34M$72.05M$82.15M$86.83M$88.25M
    Interest Income$-13,945,000$0$0$0$-10,203,000$0$0$0$0$0$0$0
    Interest Expense$13.98M$11.43M$10.67M$10.04M$9.98M$10.76M$11.46M$12.28M$13.14M$15.26M$16.57M$17.61M
    Income Before Tax$38.54M$64.77M$61.81M$69.13M$61.78M$73.96M$80.15M$71.66M$58.41M$67.32M$69.58M$70.42M
    Income Tax Expense$9.36M$10.84M$15.12M$26.92M$14.31M$23.83M$19.12M$17.29M$9.35M$17.86M$16.53M$16.86M
    Net Income$29.18M$53.93M$46.70M$42.21M$47.47M$50.13M$61.03M$54.38M$49.07M$49.46M$53.05M$53.56M
    EBITDA$64.54M$85.01M$80.53M$87.28M$80.09M$92.41M$98.91M$92.30M$80.13M$91.94M$95.22M$96.98M
    EBIT$52.49M$76.20M$72.49M$79.17M$71.98M$84.72M$91.61M$83.94M$71.55M$82.58M$86.15M$88.02M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PBH

    News

    Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?

    Prestige Consumer Healthcare (PBH) is focused on brand-building, supported by acquisitions like Breathe Right and LaCorium, and experiencing strong e-commerce growth. However...

    TradingView•10/15/26•Somewhat-Bullish

    Results are scheduled before the market opens Nov. 5. The call is set for 8:30 a.m. ET.

    Prestige Consumer Healthcare (NYSE: PBH) announced it will release its fiscal 2027 second-quarter and first-half earnings on November 5, 2026...

    Stock Titan•10/14/26•Neutral

    How (PBH) Movements Inform Risk Allocation Models

    This article analyzes Prestige Consumer Healthcare Inc. (NYSE: PBH) using AI models to provide trading strategies and risk allocation insights. It identifies a near-term positive sentiment with a potential shift...

    Stock Traders Daily•10/13/26•Somewhat-Bullish

    Prestige Consumer Healthcare acquires Breathe Right for $1.045bn

    Prestige Consumer Healthcare Inc. has acquired the Breathe Right brand and other associated brands from Foundation Consumer Healthcare for $1.045 billion. This strategic acquisition...

    scanx.trade•10/8/26•Bullish

    DEAN INVESTMENT ASSOCIATES, LLC's Prestige Consumer Healthcare Inc(PBH) Holding History

    This article details DEAN INVESTMENT ASSOCIATES, LLC's historical holdings in Prestige Consumer Healthcare Inc (PBH). As of June 30, 2026, the firm holds 0 shares of PBH, resulting in 0% of its portfolio. Over time...

    GuruFocus•10/8/26•Somewhat-Bullish

    PBH Valuation and Fair Value

    P/E
    11.7x
    Forward P/E
    10.6x
    EV/EBITDA
    13.6x
    P/FCF
    9.9x
    PEG
    1.5x
    P/B
    1.2x
    See GNG's fair value

    PBH Profitability: Margins, ROIC and FCF

    Gross margin
    53.5%
    Operating margin
    20.8%
    Net margin
    15.6%
    ROIC
    5.2%
    ROE
    9.1%
    FCF margin
    21.3%
    FCF yield
    10.1%

    PBH Competitors

    CompanyTicker
    Supernus Pharmaceuticals IncSUPN
    UFP Technologies IncUFPT
    89bio IncETNB
    Day One Biopharmaceuticals IncDAWN
    HUTCHMED DRCHCM
    Perrigo Company PLCPRGO
    MBX Biosciences, Inc. Common StockMBX
    Bausch Health Companies IncBHC

    Sector: Healthcare

    PBH Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    1
    Buy
    4
    Hold
    2
    Sell
    0
    Strong Sell
    0

    PBH Bull Case vs Bear Case

    Bull case

    • PBH converts 21.3% of revenue into free cash flow.
    • 71.4% of PBH's analyst ratings are Buy or Strong Buy.

    PBH Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -1.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.07
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About PBH

    Does PBH pay dividends?

    Prestige Brand Holdings Inc (PBH) does not currently pay a regular dividend.

    What is PBH's P/E ratio?

    Prestige Brand Holdings Inc has a price-to-earnings (P/E) ratio of 11.69.

    What is PBH's market cap?

    Prestige Brand Holdings Inc (PBH) has a market capitalization of $2.29B with a current stock price of $49.23.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In